Antibody Development and Production Services

Antibodies have become essential in various research areas and therapeutic applications. Whether you should use custom antibody production services depends on several factors:

• Specificity Requirements: Do you need antibodies with exceptional specificity to target your antigen precisely?
• Affinity Requirements: Do you need high-affinity antibodies for sensitive detection applications?
• Available Resources: Do you have the expertise and equipment to produce antibodies in-house?
• Timeline Constraints: Do you need high-quality antibodies quickly without extensive optimization?
• Commercial vs. Research Grade: Are you seeking GMP-grade antibodies for therapeutic development?

If you answered yes to any of these questions, our custom antibody production services can provide significant benefits.

Polyclonal Antibodies (pAbs):

• Advantages:
  • Recognize multiple epitopes on the same antigen
  • Often show high-affinity binding
  • Generally more robust across different assay conditions
  • Faster and more cost-effective to produce
  • Excellent for detection in Western blotting and immunohistochemistry
• Disadvantages:
  • Batch-to-batch variability due to animal immunization variation
  • May have cross-reactivity with related proteins
  • Cannot be propagated indefinitely

Monoclonal Antibodies (mAbs):

• Advantages:
  • Highly specific—recognize a single epitope
  • Consistent batch-to-batch performance
  • Can be produced in unlimited quantities
  • Ideal for therapeutic applications requiring high specificity
  • Lower cross-reactivity risk
• Disadvantages:
  • Generally more expensive and time-consuming to produce
  • May require optimization for diverse detection methods
  • Sometimes show lower affinity than polyclonals

Recommendation: Choose polyclonal antibodies for applications where multiple epitopes are advantageous and cost-efficiency is critical. Select monoclonal antibodies when you need high specificity, consistency, or large quantities for therapeutic applications.

Our custom antibody development services accept a wide range of antigen types:

• Peptides & Protein Fragments: Synthetic peptides (typically 8-20 amino acids) and recombinant protein fragments for targeting specific epitopes
• Recombinant Proteins: His-tagged, GST-tagged, or other engineered protein constructs
• Native/Purified Proteins: Full-length native proteins or naturally purified antigens from tissues or cell lysates
• Whole Cells & Cell Lysates: Mammalian cells, bacterial cells, plant cells, or cell extracts for antibodies against cellular antigens
• DNA/RNA Vaccines: Expression vectors and plasmids encoding target antigens
• Small Molecules: Haptens conjugated to carrier proteins for immunization against small molecular targets
• Anti-Idiotype Antibodies: Antibodies against other antibodies for research and therapeutic applications

Our scientific team will help select the optimal antigen format and immunization strategy to maximize antibody quality and yield.

Converting a research-grade antibody into a therapeutic candidate requires several key modifications:

• Humanization:
  • Replace murine or other non-human antibody framework regions with human sequences
  • Preserve complementarity-determining regions (CDRs) for target recognition
  • Reduces immunogenicity in human patients and improves serum half-life
• Affinity Maturation:
  • Use directed mutagenesis or phage display to identify variants with higher binding affinity
  • Optimize for improved target selectivity and reduced off-target effects
  • Enhances therapeutic efficacy at lower doses
• GMP Manufacturing:
  • Establish manufacturing processes under Good Manufacturing Practice (GMP) guidelines
  • Ensure quality, purity, and consistency across production batches
• Regulatory Compliance:
  • Conduct preclinical safety, pharmacokinetics, and immunogenicity studies
  • Prepare IND (Investigational New Drug) application for regulatory approval

HUABIO offers consultative services to guide antibody engineering for therapeutic development.